Zacks: Brokerages Expect UnitedHealth Group Incorporated (UNH) Will Post Earnings of $2.38 Per Share
Equities research analysts expect UnitedHealth Group Incorporated (NYSE:UNH) to post earnings of $2.38 per share for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for UnitedHealth Group’s earnings, with the lowest EPS estimate coming in at $2.35 and the highest estimate coming in at $2.41. UnitedHealth Group posted earnings of $1.96 per share in the same quarter last year, which would indicate a positive year over year growth rate of 21.4%. The business is expected to issue its next earnings results before the market opens on Tuesday, July 18th.
On average, analysts expect that UnitedHealth Group will report full year earnings of $9.80 per share for the current fiscal year, with EPS estimates ranging from $9.75 to $9.85. For the next financial year, analysts forecast that the business will post earnings of $10.75 per share, with EPS estimates ranging from $10.67 to $11.00. Zacks’ EPS averages are an average based on a survey of research analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.20. The business had revenue of $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. UnitedHealth Group had a return on equity of 21.42% and a net margin of 4.13%. The company’s revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.81 EPS.
UNH has been the subject of a number of research reports. Wells Fargo & Company reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, February 21st. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $177.00 price target for the company in a research report on Wednesday, February 22nd. Leerink Swann boosted their price target on UnitedHealth Group from $195.00 to $210.00 and gave the company a “hold” rating in a research report on Tuesday, February 28th. Deutsche Bank AG initiated coverage on UnitedHealth Group in a research report on Wednesday, April 5th. They set a “buy” rating and a $183.00 price target for the company. Finally, Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a research report on Wednesday, April 5th. Two analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $184.23.
UnitedHealth Group (NYSE:UNH) traded up 0.66% during trading on Monday, hitting $182.82. The stock had a trading volume of 2,249,448 shares. The firm has a market cap of $176.18 billion, a price-to-earnings ratio of 23.40 and a beta of 0.65. UnitedHealth Group has a one year low of $132.39 and a one year high of $183.76. The stock’s 50-day moving average is $176.17 and its 200 day moving average is $166.97.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, June 15th. This represents a $3.00 annualized dividend and a yield of 1.65%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.63. UnitedHealth Group’s dividend payout ratio is presently 37.36%.
TRADEMARK VIOLATION NOTICE: This article was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/06/19/zacks-brokerages-expect-unitedhealth-group-incorporated-unh-will-post-earnings-of-2-38-per-share.html.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total transaction of $2,387,560.00. Following the sale, the executive vice president now owns 31,993 shares in the company, valued at $5,456,086.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kenneth Irwin Shine sold 838 shares of the company’s stock in a transaction that occurred on Wednesday, April 19th. The shares were sold at an average price of $169.12, for a total value of $141,722.56. Following the sale, the director now owns 28,528 shares in the company, valued at approximately $4,824,655.36. The disclosure for this sale can be found here. Insiders have sold 30,378 shares of company stock worth $5,285,052 in the last 90 days. 0.89% of the stock is currently owned by insiders.
A number of hedge funds have recently made changes to their positions in UNH. Aberdeen Asset Management PLC UK boosted its stake in shares of UnitedHealth Group by 21.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 662,179 shares of the healthcare conglomerate’s stock valued at $105,975,000 after buying an additional 118,949 shares during the last quarter. Barbara Oil Co. boosted its stake in shares of UnitedHealth Group by 28.0% in the fourth quarter. Barbara Oil Co. now owns 6,400 shares of the healthcare conglomerate’s stock valued at $1,024,000 after buying an additional 1,400 shares during the last quarter. Rainier Group Investment Advisory LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $215,000. Calamos Advisors LLC boosted its stake in shares of UnitedHealth Group by 63.2% in the fourth quarter. Calamos Advisors LLC now owns 437,830 shares of the healthcare conglomerate’s stock valued at $70,070,000 after buying an additional 169,545 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $575,000. Hedge funds and other institutional investors own 86.73% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.